Roumane, AhlimaMcilroy, George DSommer, NadineHan, WeipingHeisler, Lora KRochford, Justin J2024-06-262024-06-262024-04-30Roumane, A, Mcilroy, G D, Sommer, N, Han, W, Heisler, L K & Rochford, J J 2024, 'GLP-1 receptor agonist improves metabolic disease in a pre-clinical model of lipodystrophy', Frontiers in Endocrinology, vol. 15, 1379228. https://doi.org/10.3389/fendo.2024.13792281664-2392PubMedCentral: PMC11091257ORCID: /0000-0003-2380-7117/work/162725823ORCID: /0000-0003-4230-4355/work/162726615ORCID: /0000-0002-5020-4939/work/162727005https://hdl.handle.net/2164/23717Acknowledgments The authors would like to thank the staff at the University of Aberdeen’s Microscopy and Histology Core Facility, the Medical Research Facility and Prof. Mirela Delibegovic for technical support and advice with the in vivo studies. The Graphical Abstract was created with BioRender.Com. Ethics statement The animal study was approved by Animal procedures were approved by the University of Aberdeen Ethics Review Board. The study was conducted in accordance with the local legislation and institutional requirements.114247631engSubstantive connection via an eligible employment contractSDG 3 - Good Health and Well-beingAnimalsLiraglutide/pharmacologyGlucagon-Like Peptide-1 Receptor/agonistsMiceMice, KnockoutDisease Models, AnimalInsulin ResistanceLipodystrophy/drug therapyMaleMetabolic Diseases/drug therapyBlood Glucose/metabolismInsulin/metabolismHypoglycemic Agents/pharmacologyMice, Inbred C57BLR MedicineSupplementary DataRJournal article10.3389/fendo.2024.1379228